Navigation Links
CELLECTA, INC. to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research, Inc.
Date:9/16/2009

The goal of Cellecta's second project with RPCI is to develop, optimize, and perform high-throughput insertional mutagenesis screens to identify potential cancer drug targets.

Mountain View, CA (PRWEB) September 16, 2009 -- Cellecta, Inc., a biotech contract research company which performs high-throughput (HT) RNAi and peptide genetic screens for novel therapeutic target and drug discovery, announced today that it has been awarded a subcontract to assist the scientists at Roswell Park Cancer Institute and Health Research, Inc. in developing a new technology for the discovery of cancer-related genes using HT insertional mutagenesis.

The Principal Investigator of this NIH-funded study, Dr. Eugene Kandel, states "There are many people who can appreciate new ideas about sophisticated molecular technologies when these are described on paper. There are some people who can implement such ideas in practice. And there are very few who can do it in a way that is robust, reproducible and easy for others to follow. That is why I am very happy to have the scientists of Cellecta helping me in the development of the new gene discovery method. These people were behind some of the most innovative techniques that had been popularized by renowned biotech companies, and now I am hoping for the same success for our method as well."

The Founder, CEO, and Scientific Director of Cellecta, Dr. Alex Chenchik, says that "Roswell Park Cancer Institute and Health Research, Inc. have both demonstrated a high level of confidence in Cellecta with this contract award, and we look forward to combining our efforts to develop a sophisticated and robust technology to accelerate the discovery of cancer-related genes."

About Cellecta, Inc.

Cellecta was founded in April of 2006 with a mission to develop the most advanced high-throughput (HT) RNAi and peptide screen technologi
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
2. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
3. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
4. Pharmatek Adds Cytotoxic and High-Potent Drug Development Capabilities to San Diego Laboratory
5. Global Experts Explore Entire Spectrum of Aids Vaccine Development
6. Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
7. Vical Names Andrew de Guttadauro Vice President, Corporate Development
8. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
9. SemBioSys updates Apo AI development program
10. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
11. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CELLECTA, INC. to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research, Inc.
(Date:5/5/2015)... Hills, MI (PRWEB) May 05, 2015 ... premier Parker Hannifin distributor, announces the launch of ... provide fleet operators with a convenient way to ... maintenance products . , The new ... to 100,000 vehicles with direct access to high ...
(Date:5/4/2015)... Many of us take a healthy ... with rare, inherited mutations of certain genes, severe ... impaired immune responses. Now, researchers at ... role for calcium signaling in immune responses to ... causing tuberculosis (TB). Specifically, they ...
(Date:5/4/2015)... May 4, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) ... on Form 20-F for the fiscal year ended December ... ("SEC"). The annual report on Form 20-F contains information ... in the area of cancer immune checkpoints. This project ... high specificity and binding in targeting certain identified immune ...
(Date:5/4/2015)... Genedata, a leading provider of advanced ... research, today announced the release of Genedata ... enterprise solution for biologics R&D. This first-in-class workflow ... and development of novel biotherapeutics. Version 5.0 enables ... optimization and developability requirements. Genedata will present highlights ...
Breaking Biology Technology:Exotic Automation & Supply Launches Ecommerce Website 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 2Researchers Discover A Novel And Unexpected Role For Calcium In Controlling Inflammation During Chronic Lung Infection 3Tikcro Technologies Files Annual Report on Form 20-F for the Year Ended December 31, 2014 2Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 2Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 3Genedata Biologics 5.0 – Antibody Engineering and Developability Assessment Advances 4
... the Georgia Institute of Technology has developed a ... how space vehicles and instruments are designed. The ... which can produce electronics that are highly resistant ... Titled "SiGe Integrated Electronics for Extreme Environments," ...
... University of Technology and Oxford University announce a new type ... cheap genetic analysis. In the journal Nature Nanotechnology ... man-made and biological materials to result in a tiny hole ... single DNA molecules. Biological , "The first mapping ...
... female fruit fly. Being a looker is simply not enough. To ... like a girl, even smell like one. Otherwise, you might just ... fruit flies must distinguish between a potential mate and a potential ... he,ll court; when he senses the other is a male, he,ll ...
Cached Biology Technology:Project pioneers use of silicon-germanium for space electronics applications 2Project pioneers use of silicon-germanium for space electronics applications 3Project pioneers use of silicon-germanium for space electronics applications 4Project pioneers use of silicon-germanium for space electronics applications 5Fitting a biological nanopore into a man-made one, new ways to analyze DNA 2Battle of the sexes, fruit-fly style 2
(Date:4/9/2015)... 9, 2015 Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the third ... after the close of market. The company will host ... 2:00 p.m. PT (5:00 p.m. ET), during which management ... on the live call, analysts and investors should dial ...
(Date:4/2/2015)... April 2, 2015 At its 2015 ACMG ... City , the American College of Medical Genetics ... directors to its Board.  Members of the ACMG Board ... for forming and advancing its policies and programs. ACMG ... "It,s an eventful time in medical genetics ...
(Date:4/1/2015)... April 1, 2015   Medisafe ™, the leading ... across iOS and Android smartphones ... biofeedback into the platform to allow patients to track ... the first time, patients will be able to visualize ... impacts important biometrics, such as glucose levels and blood ...
Breaking Biology News(10 mins):Synaptics to Report Third Quarter Results on April 23 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2
... has found genetic evidence of how some plants adapt to ... day be used to help food crops survive in new ... noticed several years ago that a variant of the research ... had come from coastal areas. To test the observation, Salt ...
... In a demonstration of "reverse-ecology," biologists at the University ... organism,s adaptive traits by looking first at its genome and ... to be published the week of Jan. 31 in the ... offers a powerful new tool in evolutionary genetics research, one ...
... have found that free radicals (unstable molecules that cause the ... the damage in the eyes of patients with Fuchs Endothelial ... the most common reasons for corneal transplants worldwide. ... of Pathology , holds promise for early and preventative treatments ...
Cached Biology News:Plants can adapt genetically to survive harsh environments 2Analysis of bread mold genomes demos 'reverse-ecology' tool 2Analysis of bread mold genomes demos 'reverse-ecology' tool 3Free radicals in cornea may contribute to Fuchs dystrophy, most common cause of corneal transplants 2